N- (6-AMINOPYRIDIN-3-YL) -3- (SULFONAMIDO) BENZAMIDE DERIVATIVES AS B-RAF INHIBITORS FOR THE TREATMENT OF CANCER
申请人:Ahrendt Kateri A.
公开号:US20110003859A1
公开(公告)日:2011-01-06
Compounds of Formula (I) are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
式(I)的化合物可用于抑制Raf激酶。本文揭示了使用式(I)的化合物及其立体异构体和药物可接受的盐,在哺乳动物细胞中进行体外、体内诊断、预防或治疗相关病理条件的方法。